Prospero homeobox protein 1 mRNA 3′ untranslated region (PROX1 mRNA 3′UTR)

The PROX1 mRNA 3′UTR is a critical regulatory segment of the messenger RNA encoding the Prospero homeobox protein 1, a master transcription factor essential for the development of the lymphatic system, liver, and sensory organs. This 3′UTR is notably long, often exceeding 5 kb, and contains numerous cis-regulatory elements, including AU-rich elements (AREs) and binding sites for various microRNAs such as miR-181a, miR-489, and miR-31. These elements allow for precise post-transcriptional control of PROX1 levels, which is vital because aberrant PROX1 expression is a hallmark of several pathologies, particularly in promoting tumor lymphangiogenesis and metastasis in colorectal and gastric cancers. In the context of drug discovery, the PROX1 mRNA 3′UTR is an attractive therapeutic target for RNA-based modalities. Experimental strategies utilize miRNA mimics to downregulate PROX1 in oncogenic settings or antisense oligonucleotides to modulate its stability by interfering with RNA-binding proteins like HuR (ELAVL1). Because PROX1 acts as a molecular switch for cell identity, targeting its 3′UTR offers a programmable approach to rewiring cellular behavior in cancer and regenerative medicine.

Other names

PROX1 3′UTRProspero-related homeobox 1 3′ untranslated regionPROX1 3′-untranslated region

Drugs targeting the PROX1 mRNA 3′UTR typically function through RNA interference (RNAi) or antisense mechanisms. MicroRNA (miRNA) mimics bind to specific seed-match sequences within the 3′UTR to induce mRNA degradation or translational repression. Conversely, antisense oligonucleotides (ASOs) can be designed to either trigger RNase H-mediated cleavage of the transcript or block the binding of stabilizing RNA-binding proteins (RBPs) like HuR, thereby reducing PROX1 protein expression.